Neamah et al., 2019 - Google Patents
Comparative evaluation of biochemical profiling of 4', 4”-(4, 5, 6, 7-TETRAHYDRO-[1, 2, 3-] SELENADIAZOLO [4, 5e] PYRIDINE-4, 6-DIYL) BIS (BENZENE-1, 3-DIOL) …Neamah et al., 2019
View PDF- Document ID
- 16566239733769348933
- Author
- Neamah N
- Khudair A
- Al-Jadaan S
- Publication year
- Publication venue
- Journal of Physics: Conference Series
External Links
Snippet
The current study has been carried out at the department of pharmaceutical chemistry, College of pharmacy. Novel synthetically selenium-containing compounds have potential therapeutic effects towards several diseases, such as: cancer microbial infections and …
- 241000700159 Rattus 0 title abstract description 44
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jiang et al. | Inonotus obliquus polysaccharides induces apoptosis of lung cancer cells and alters energy metabolism via the LKB1/AMPK axis | |
| Marreiro et al. | Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women | |
| Liu et al. | Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats | |
| Clarke et al. | Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects | |
| Rasekh et al. | Acute and subchronic oral toxicity of Galega officinalis in rats | |
| Kim et al. | Attenuation of bacterial lipopolysaccharide-induced hepatotoxicity by betaine or taurine in rats | |
| Vanhorebeek et al. | Hyperglycemic kidney damage in an animal model of prolonged critical illness | |
| Liu et al. | Allicin improves carotid artery intima-media thickness in coronary artery disease patients with hyperhomocysteinemia | |
| Rasmussen et al. | Determination of the safety of leucine supplementation in healthy elderly men | |
| Tan et al. | Dynamic changes in blood flow and oxygen consumption in the portal-drained viscera of growing pigs receiving acute administration of L-arginine | |
| Deng et al. | Chitosan oligosaccharide ameliorated obesity by reducing endoplasmic reticulum stress in diet-induced obese rats | |
| Li et al. | Therapeutic potential of buckwheat hull flavonoids in db/db mice, a model of type 2 diabetes | |
| Bilge et al. | Relationship between 1, 25‑dihydroxy Vitamin D levels and homeostatic model assessment insulin resistance values in obese subjects | |
| CN103566198B (en) | Application of gastrodia elata and gastrodin in the preparation of products for treating non-alcoholic fatty liver | |
| Bassil et al. | Hyperaminoacidaemia at postprandial levels does not modulate glucose metabolism in type 2 diabetes mellitus | |
| Barber et al. | Modulation of the liver export protein synthetic response to feeding by an n− 3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients | |
| Neamah et al. | Comparative evaluation of biochemical profiling of 4’, 4”-(4, 5, 6, 7-TETRAHYDRO-[1, 2, 3-] SELENADIAZOLO [4, 5e] PYRIDINE-4, 6-DIYL) BIS (BENZENE-1, 3-DIOL) and dipyrone on female rat’s | |
| Shari et al. | Hypolipidemic and Antioxidant Effects of Fenugreek-Nigella Sativa Combination on Diabetic Patients in Iraq. | |
| Doolan et al. | Renal clearance of lysine in cystinuria: pathogenesis and management of this abnormality | |
| Adeyemi et al. | Effects of salmon calcitonin and omega–3 fatty acids on selected biomarkers in experimental diabetic–osteoarthritic rats | |
| EP3574912B1 (en) | Composition for treating diabetic disease | |
| RI et al. | The mechanisms of plant rhizome Curcuma longa action on carbohydrate metabolism in alloxan-induced diabetes mellitus rats | |
| Mirhashemi et al. | Metabolic response to omega-3 fatty acids and vitamin E Co-supplementation in patients with fibrocystic breast disease: a randomized, double-blind, placebo-controlled trial | |
| Nasir et al. | Nutritional status of children living with HIV and receiving antiretroviral (ARV) medication in the Klang Valley, Malaysia. | |
| James et al. | Glucose tolerance test and some biochemical effect of Phyllanthus amarus aquoeus extacts on normaglycemic albino rats |